GTBPVSHALO• 28 Days (Normalized)
GTBP vs HALO (GT Biopharma Inc. vs Halozyme Therapeutics Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+2.01%
GT Biopharma Inc.
Normalized Baseline0.00%
HALO Performance $109.86
+1.43%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+0.58 pts
GTBP outperforming by 0.58 percentage points
GTBPHALO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP HALO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | GTBP Price | GTBP Gain (%) | HALO Price | HALO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +2.01% | $109.86 | +1.43% | +0.58% |
| Oct 01, 2026 | $- | $106.94 | -1.26% | - | |
| Sep 30, 2026 | $- | $110.40 | +1.93% | - | |
| Sep 29, 2026 | $6.88 | +14.97% | $111.56 | +3.00% | +11.97% |
| Sep 28, 2026 | $6.80 | +13.71% | $112.89 | +4.23% | +9.48% |
| Sep 25, 2026 | $6.89 | +15.22% | $113.90 | +5.16% | +10.06% |
| Sep 24, 2026 | $6.83 | +14.21% | $- | - | |
| Sep 23, 2026 | $7.10 | +18.73% | $112.44 | +3.81% | +14.92% |
| Sep 22, 2026 | $- | $115.13 | +6.30% | - | |
| Sep 21, 2026 | $7.18 | +20.07% | $111.45 | +2.90% | +17.17% |
| Sep 18, 2026 | $7.16 | +19.73% | $112.45 | +3.82% | +15.91% |
| Sep 17, 2026 | $7.49 | +25.25% | $109.68 | +1.26% | +23.99% |
| Sep 16, 2026 | $7.81 | +30.60% | $108.44 | +0.12% | +30.48% |
| Sep 15, 2026 | $9.00 | +50.50% | $106.25 | -1.90% | +52.40% |
| Sep 14, 2026 | $11.63 | +94.48% | $107.94 | -0.34% | +94.82% |
Page 1 of 2